128 related articles for article (PubMed ID: 3026107)
1. Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
Chen MH; Zhou Z; Hartley CE; Cowan M; Skinner GR
Vaccine; 1986 Dec; 4(4):249-52. PubMed ID: 3026107
[TBL] [Abstract][Full Text] [Related]
2. Prevention of type 2 herpes simplex virus induced cervical carcinoma in mice by prior immunization with a vaccine prepared from type 1 herpes simplex virus.
Chen MH; Dong CY; Liu ZH; Skinner GR; Hartley CE
Vaccine; 1983 Dec; 1(1):13-6. PubMed ID: 6099637
[TBL] [Abstract][Full Text] [Related]
3. Antibody reactivity with Skinner HSV vaccine.
Muniu EM; Durham J; Shariff D; Hartley CE; Fuller A; Melling J; Wiblin C; Wilkins G; Buchan A; Skinner GR
Med Microbiol Immunol; 1987; 176(6):315-27. PubMed ID: 2828898
[TBL] [Abstract][Full Text] [Related]
4. Promoting effect of croton oil on the induction of cervical and vaginal cancers with herpes simplex virus types 1 and 2 in mice.
Man YG; Chen MH
Gynecol Oncol; 1989 Apr; 33(1):27-33. PubMed ID: 2539313
[TBL] [Abstract][Full Text] [Related]
5. Cervical carcinoma: an experimental approach.
Cowan ME; Skinner GR
Cancer Surv; 1988; 7(3):469-79. PubMed ID: 2853998
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
[TBL] [Abstract][Full Text] [Related]
7. Genital herpes.
Oates JK
Br J Hosp Med; 1983 Jan; 29(1):13-22. PubMed ID: 6297643
[No Abstract] [Full Text] [Related]
8. Clinical efficacy of a herpes simplex subunit vaccine.
Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies with herpes simplex virus type 2 Curtis strain vaccine.
Corey L
Rev Infect Dis; 1991; 13 Suppl 11():S904-5. PubMed ID: 1664125
[No Abstract] [Full Text] [Related]
11. Systemic and mucosal cell mediated immune responses against herpes simplex virus in vaccinated guinea-pigs detected by lymphocyte proliferation and monoclonal antibodies against macrophages and T cells.
McBride BW; Ridgeway P; Phillpotts R; Newell DG
Vaccine; 1989 Oct; 7(5):409-16. PubMed ID: 2554606
[TBL] [Abstract][Full Text] [Related]
12. A test for the relative potency of herpes simplex virus vaccines based upon the female guinea-pig model of HSV 2 genital infection.
Phillpotts RJ; Welch MJ; Ridgeway PH; Walkland AC; Melling J
J Biol Stand; 1988 Apr; 16(2):109-18. PubMed ID: 2836425
[TBL] [Abstract][Full Text] [Related]
13. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
Skinner GR; Woodman CB; Hartley CE; Buchan A; Fuller A; Durham J; Synnott M; Clay JC; Melling J; Wiblin C; Wilkins J
Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
[TBL] [Abstract][Full Text] [Related]
14. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
Berman PW; Gregory T; Crase D; Lasky LA
Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
[TBL] [Abstract][Full Text] [Related]
15. Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine.
Skinner GR; Fink CG; Cowan M; Buchan A; Fuller A; Hartley CE; Durham J; Wiblin C; Melling J
Med Microbiol Immunol; 1987; 176(3):161-8. PubMed ID: 3037289
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus in pregnancy: new concepts in prevention and management.
Hill J; Roberts S
Clin Perinatol; 2005 Sep; 32(3):657-70. PubMed ID: 16085025
[TBL] [Abstract][Full Text] [Related]
17. [The role of herpetic infection in epithelial dysplasias of the cervix uteri and a trial of their treatment with antiherpetic preparations].
Posevaia TA; Tsukerman VG; Shuvaeva NI; Busuek IN; Barinskiĭ IF
Vopr Virusol; 1991; 36(1):78-80. PubMed ID: 1650068
[No Abstract] [Full Text] [Related]
18. Herpes simplex virus. An expanding relationship to human cancer.
Smith JW
J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
Skinner GR; Buchan A; Williams D; Marsden J; Hartley C; Wilbanks G; Turyk M; Namkoong ES
Br J Exp Pathol; 1982 Aug; 63(4):378-87. PubMed ID: 6295430
[TBL] [Abstract][Full Text] [Related]
20. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
Welch MJ; Ridgeway PH; Phillpotts RJ
FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]